Senior Research Scientist
Elanco
Summary
As a Research Scientist / Project Leader on our Discovery Parasiticides team, you will architect the future of animal health by playing a pivotal role in the early research phase. You will spearhead the identification of next-generation molecular hits against endo- and ectoparasites. In this role, you will lead the discovery and interpretation of critical in vitro and in vivo data, championing the selection process for New Molecular Entities (NME) and ensuring a robust pipeline for both Pet Health and Farm Animals.
Job description
Your Role: Research Scientist / Project Leader
As a Research Scientist / Project Leader on our Discovery Parasiticides team, you will architect the future of animal health by playing a pivotal role in the early research phase. You will spearhead the identification of next-generation molecular hits against endo- and ectoparasites. In this role, you will lead the discovery and interpretation of critical in vitro and in vivo data, championing the selection process for New Molecular Entities (NME) and ensuring a robust pipeline for both Pet Health and Farm Animals.
Your Responsibilities
- Lead research activities to identify and validate novel targets using multi-omics (transcriptomics, proteomics) and functional models for small/large molecules and vaccines.
- Drive discovery programs from concept to candidate selection, ensuring scientific rigor and meeting timeline milestones for next-generation parasiticides.
- Lead multi-functional, international teams to influence selection and transition candidates seamlessly into the development pipeline.
- Oversee the generation and interpretation of complex biological datasets (in vitro/in vivo) to guide high-stakes decision-making.
- Manage a strategic network with academic institutions and contract research organizations in close collaboration with the External Innovation Team to achieve research goals.
What You Need to Succeed (minimum qualifications)
- Education: PhD in Biology, Veterinary Medicine, Parasitology, or a related scientific field.
- Experience: A minimum of 4 years of industrial R&D experience in a project leadership capacity.
- Skills: Proven track record in target identification and validation within Animal Health or Pharma; demonstrated success leading complex cross-functional teams without direct authority.
What will give you a competitive edge (preferred qualifications)
- Solid understanding of AI/ML and in silico modelling to accelerate discovery.
- Deep knowledge of parasite biology and modern screening methodologies.
- Excellent communication skills with the ability to influence and translate complex data for diverse stakeholders.
- High resilience and adaptability in a fast-paced, high-growth environment.
Additional Information
- Location & Work Model: Indianapolis, IN (Global HQ) with a Hybrid work model.
- Travel: Up to 15% annually.
Requirements
- PhD in Biology, Veterinary Medicine, Parasitology, or a related scientific field
- Minimum of 4 years of industrial R&D experience in a project leadership capacity
- Proven track record in target identification and validation within Animal Health or Pharma
- Demonstrated success leading complex cross-functional teams without direct authority
Benefits
- Relocation packages
- Two weeklong shutdowns
- 8-week parental leave
- 9 Employee Resource Groups
- Annual bonus
- Flexible work arrangements
- Up to 6% 401K matching
Company overview
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.